stockrow
Friday 6 November 2026
Export SNYRQ’s income statement to Excel — free account
Synergy CHC Corp.
SNYRQ Healthcare Medical Distribution
Synergy CHC Corp.’s revenue for fiscal 2025 (year ended December 2025) was $30.4 million, down 12.8% from fiscal 2024.
- Revenue
- −32.8%
- EPS
- −330.0%
- Free cash flow
- −148.5%
- Total debt
- +7.08%
Quarter to March 2026, against a year earlier
0.00
0.00
NaN
Follow SNYRQ
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
P/E ratio |
0.00 | 15.85 | 0.02 | 0.02 |
Piotroski F-Score |
2 | 3 | — | — |
Altman Z-Score |
(7.00) | 0.05 | — | — |
P/S ratio |
0.60 | 0.96 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(23.28) | (7.39) | (8.28) | (23.57) |
P/FCF ratio |
0.00 | 0.00 | 0.04 | 0.04 |
P/Operating CF |
28.98 | (9.75) | (0.31) | 0.00 |
Beneish M-Score |
(7.98) | 0.60 | (0.60) | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.33 | 1.50 | 0.81 | 0.00 |
EV/EBITDA |
0.00 | 8.74 | 4.27 | 0.00 |
EV/Operating CF |
(15.67) | (10.91) | 16.16 | 0.00 |
EV/FCF |
(15.67) | (10.91) | 16.16 | 0.00 |
Quick Ratio |
0.72 | 0.73 | 0.52 | 0.34 |
Current Ratio |
1.22 | 0.93 | 0.84 | 0.61 |
Net Debt/EBITDA |
(3.35) | 3.17 | 2.28 | (0.79) |
Debt/Assets |
247.50% | 121.09% | 208.53% | 117.68% |
Debt/Equity |
(1.09) | (1.19) | (0.93) | (0.65) |
Asset Turnover |
2.29 | 2.44 | 2.78 | 0.00 |
Operating CF/Net income |
0.21 | (2.26) | 0.07 | 0.26 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(1.43) | 1.41 | 2.55 | (4.06) |
| 62.08% | (9.67%) | (20.84%) | 0.00% | |
| (93.11%) | 14.87% | 41.19% | 0.00% | |
ROIC |
0.00% | 152.93% | 0.00% | 0.00% |
Return on Tangible Assets |
(693.99%) | (188.96%) | (288.26%) | 278.41% |
Average Days of Receivables |
38.49 | 122.55 | 56.03 | 75.14 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
72.31% | 50.84% | 49.65% | 98.15% |
Intangible Assets out of Total Assets |
0.01 | 0.02 | 0.03 | 0.00 |
Share Based Compensation of Revenue |
3.66% | 0.28% | 0.00% | 0.00% |
Graham Net Nets |
(1.29) | (0.51) | (345.62) | 0.00 |
Graham Number |
7.57 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(57.53%) | 6.31% | 4,376.00% | 4,376.00% |
Free Cash Flow Yield |
(14.29%) | (14.39%) | 2,417.01% | 2,417.01% |
Revenue per Share |
3.12 | 4.59 | 5.80 | 5.08 |
Operating CF per Share |
(0.27) | (0.63) | 0.06 | (1.12) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.27) | (0.63) | 0.06 | (1.12) |
Cash per Share |
0.28 | 0.10 | 0.10 | 0.33 |
Shareholders Equity per Share |
(2.38) | (2.19) | (3.70) | (4.44) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(2.38) | (2.19) | (3.70) | (4.44) |
Free Cash Flow |
(2.58) | (4.80) | 0.42 | (8.43) |
Working Capital |
1.78 | (1.12) | (2.20) | (11.72) |
Net Current Asset Value |
(23.28) | (16.91) | (27.72) | (33.52) |
EV/EBIT |
0.00 | 9.03 | 4.37 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 5.76 | 0.01 | 0.01 |
| Other line items | ||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(54.41%) | (121.71%) | (40.17%) | 91.91% |
Accounts Receivable Turnover |
4.08 | 3.82 | 5.91 | 0.00 |
Accounts Payable Turnover |
1.74 | 1.32 | 0.66 | 0.00 |
Inventory Turnover |
3.70 | 4.11 | 1.83 | 0.00 |
Average Days of Payables |
231.36 | 169.33 | 400.15 | 302.28 |
Days of Inventory on Hand |
135.36 | 55.99 | 127.14 | 115.81 |
Average Receivables |
7.45 | 9.13 | 7.24 | — |
Average Payables |
5.79 | 8.46 | 16.26 | — |
Average Inventory |
2.73 | 2.72 | 5.85 | — |
Average Assets |
13.25 | 14.29 | 15.39 | — |
Average Common Equity |
(19.88) | (21.97) | (30.41) | — |
Columns are period end dates